Skip to main content
. 2022 Jun 15;50(6):03000605211053703. doi: 10.1177/03000605211053703

Figure 1.

Figure 1.

Expression levels of growth arrest specific 5 (GAS5) and miR-23a in CD4+ T cells of myasthenia gravis (MG) patients. (a and b) The expression levels of GAS5 and miR-23a were examined in CD4+ T cells of MG patients (n = 30) and healthy controls (n = 30) by RT-qPCR. *P < 0.05.